Prestige Biopharma announced that it has signed a technology transfer contract with HV (Human Vaccine), a subsidiary of the Russian Direct Investment Fund (RDIF), and ENSO (ENSO Healthcare DMCC), a Sputnik vaccine production partner, to produce Sputn ...